showed a trendp > 0.05
Glycolytic reserve showed a trend ( p > 0.05) for a decline, which was not statistically significant ( Figure 5 C). 3.5.
Glycolytic reserve showed a trend ( p > 0.05) for a decline, which was not statistically significant ( Figure 5 C). 3.5.
Under acute bleomycin treatment, the growth differences among the WT and single‐ and double‐KO mutants were not significantly different ( p < .01; Figure S7 ); however, all single‐ and double‐KO mutants showed a trend toward more vigorous growth than that seen in the WT ( p < .05).
Global longitudinal strain Global longitudinal strain measured by FT showed a trend towards being higher than that measured by fast‐SENC ( P value = 0.05), while fast‐SENC‐derived GLS was significantly higher than TAG ( Figure 1 and Table 1 ).
Worsening in MRC Scale score correlated significantly with the decrease in the main background frequency on FR (r=0.62, p=1.5×10 −3 ) but showed a trend, in all the other electrode groups (p<0.05).
Kaplan-Meier analysis also showed a trend of improved survival in mice treated with pevonedistat alone and in combination over the control group (p < 0.05) (Figure 6C ).
In the airway analysis, the volume increased by 6.2% ( p = 0.327), while the area showed a trend toward improvement (20%; p = 0.050), approaching statistical significance.
Body composition, measured at week 15, showed a trend to increased lean body mass in the herring-fed mice in comparison with the beef-fed (p-value = 0.050).
C4 also showed a trend of favorable prognosis (HR = 0.60, 95% C.I. 0.38-1.01; p = 0.05) ( Table 1 ).
In the age group 80 to 90, the underweight showed a trend of increased mortality compared to the normal weight, without reaching statistical significance ( p < 0.05).
In the reduced model, TMT-1 showed a trend toward significance ( p = 0.050, OR = 0.60, 95% CI: 0.36 to 1.00), suggesting that better visual perception reduced the odds of injury by approximately 40%.
Although the glaucoma group showed a trend towards poorer VRQoL on several scales, no statistically significant difference was found among the four ocular condition groups (all p > 0.05).
In subgroup analysis, hypertensive patients with high MDA were significantly older ( p = 0.03) and showed a trend towards higher systolic BP ( p = 0.05) compared to those with low MDA.
However, co-treatment of MGO-challenged COCs with the TAB cocktail showed a trend towards increased Rage mRNA expression (Fig. 6 C, P > 0.05) compared to MGO-challenged COCs alone.
The CFQ-R questionnaire showed a trend towards an improvement of the physical domain score as the majority of the patients scored higher after treatment (88% (17; 100) to 88% (58; 100), p = 0.05).
Jejunal MUC-2 expressions ( Figure 6 ) showed a trend of increase ( p > 0.05) in GTE treatments compared to the controls (with and without challenge).
Furthermore, triple-class refractory patients showed a trend toward inferior PFS (HR: 3.76, p = 0.05) and significantly worse OS (HR: 20.46, p = 0.002) compared to non-refractory patients.
Quantitative difference in GCSF-, MCP-1-, TPO- or IL-6-expression showed a trend towards a change in values, however did not reach statistical significance. hCG levels, were significantly decreased in patients with miscarriage compared to those with ongoing pregnancy (151.75 ± 25.29 IU/l vs. 351.27 ± 111.02 IU/l, p < 0.05) However, they were within normal limits and therefore not predictive for pregnancy outcome.
A one-way ANOVA showed a trend toward significant differences among the RTLE, LTLE, and healthy control groups for hippocampal activation ARs, F (2,26) = 3.37, p = 0.05.
Apremilast showed a trend to increase IL-6 in this murine cell line (from 811 ± 416 to 1,986 ± 881 pg/ml, P <0.05) and modestly diminished the LPS-mediated increase of IL-1α (from 149 ± 26 to 97 ± 35 pg/ml, P <0.05).
However, RV-GLS was significantly lower in the ID group ( p = 0.005), while TAPSE and pulmonary acceleration time showed a trend towards lower values in the ID group ( p = 0.05 for both).
2B ) showed a trend for shorter BCR with a median of 91 months (95% CI not computed) compared to 125 (111.5–158.5 months) in patients with low SOAT2 staining ( n = 247, Log rank p = 0.05).
Lesions with positive HU showed a trend toward a prevalent spine distribution as compared to those with negative HU (60% vs 38%, respectively ( p < 0.05), whereas lesions with negative HU were more represented at the site of pelvis, although not significantly (45% vs 26%, p = 0.067).
Indeed, both low-frequency (<12 Hz) and high-frequency (>18 Hz) activity actually showed a trend toward a negative correlation with the amplitude of type I slow waves ( p < 0.05, uncorrected ).
Compared with the prednisone group, %Ct.Ar and %P-L.Pm were showed a trend toward increased (P>0.05) while %Ma.Ar and E-BFR/BS were showed a trend toward decreased (P>0.05) in CAL, PMR30 and PMRF groups ( Fig. 4 and Tables V and VI ).
VAS scores generally showed a trend opposite to that of the LEFS functional scores ( P < 0.05).